nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.06.2017 | editorial

Notes from California – experts review the ASH meeting 2016 in San Diego

verfasst von: Niklas Zojer

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Excerpt

Again MEMO has asked experts in the field to review their choice of presentations from the ASH meeting 2016, held in San Diego from the 3^rd to the 6^th December last year. Reviews on selected topics in hematology were invited, reflecting dynamic advancements in understanding and treatment of hematologic disorders. Exciting times we live in as hematologists! …

Nächster Artikel Post San Antonio Breast Cancer Symposium

Heintel D. American Society of Hematology 2016 annual meeting. Novel strategies in the management of lymphoma. Memo. 2017; doi:10.1007/s12254-017-0340-6.

Bolomsky A, Ludwig H. Is there progress in the treatment of high-risk myeloma? Novel insights from ASH 2016. Memo. 2017; doi:10.1007/s12254-017-0338-0.

Agis H. News in AL Amyloidosis ASH 2016. A rapidly evolving field of investigation Memo. 2017; doi:10.1007/s12254-017-0332-6.

Pfeilstöcker M. American Society of Hematology 2016 annual meeting. Progress in myelodysplastic syndromes. Memo. 2017; doi:10.1007/s12254-017-0330-8.

Hopfinger G. Hematopoietic stem cell transplantation: up-date from ASH 2016. Memo. 2017; doi:10.1007/s12254-017-0337-1.

Feistritzer C, Mosheimer B. ASH Meeting 2016: developments in hemostaseology. Memo. 2017; doi:10.1007/s12254-017-0339-z.

Titel: Notes from California – experts review the ASH meeting 2016 in San Diego
verfasst von: Niklas Zojer
Publikationsdatum: 01.06.2017
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 2/2017
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-017-0333-5

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

ASH Meeting 2016: developments in hemostaseology

American Society of Hematology 2016 annual meeting

Brentuximab vedotin in a patient with enteropathy-associated T‑cell lymphoma of the small bowel

Is there progress in the treatment of high-risk myeloma?

Post San Antonio Breast Cancer Symposium

ASCO 2016 – update colorectal liver metastases